Latest Amnion Stories
EpiFix® shown to result in the most rapid improvement and resolution of DFUs, successful complex management of extensive life-threatening wounds, and safe and effective treatment of Stage IV Pressure
MARIETTA, Ga., Sept. 30, 2014 /PRNewswire/ -- MiMedx Group, Inc.
Study determines allografts with both amnion and chorion contain approximately 20 times more cytokines than the competitive single layer amnion allografts evaluated MARIETTA, Ga., Sept.
Company Amends its Patent Infringement Lawsuit to Include Two Additional Patents MARIETTA, Ga., April 29, 2014 /PRNewswire/ -- MiMedx Group, Inc.
EDISON, N.J., April 28, 2014 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has been notified that on April 21, 2014, MiMedx Group, Inc.
EpiFix® is shown to promote rapid healing and return to function for patients and provide a potential for significant cost savings. MARIETTA, Ga., April 23, 2014 /PRNewswire/ -- EpiFix®,
MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.